# Study of South African Dialysis Patients

> **NCT01890577** · — · TERMINATED · sponsor: **Amgen** · enrollment: 28 (actual)

## Conditions studied

- Chronic Kidney Disease, Receiving Dialysis

## Interventions

- **DRUG:** Aranesp

## Key facts

- **NCT ID:** NCT01890577
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Study was terminated due to slow enrolment with no reasonable expectation of attaining a meaningful sample size
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890577, "Study of South African Dialysis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01890577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*